Amgen Inc. · Thousand Oaks, CA United States (NASDAQ: AMGN)
Key Amgen Inc. Financials
| Company Type | Public -(NASDAQ: AMGN) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Sales (mil.) | $15,582.0 |
| 2010 Employees | 17,400 |
Amgen Inc. Income Statement
| Dec 11 | Dec 10 | Dec 09 | |
| Revenue | 15,582.0 | 15,053.0 | 14,642.0 |
| Cost of Goods Sold | 2,427.0 | 2,220.0 | 2,091.0 |
| Gross Profit | 13,155.0 | 12,833.0 | 12,551.0 |
| Gross Profit Margin | 84.4% | 85.3% | 85.7% |
| SG&A Expense | 4,486.0 | 3,983.0 | 3,820.0 |
| Depreciation & Amortization | 294.0 | 294.0 | 294.0 |
| Operating Income | 4,312.0 | 5,545.0 | 5,506.0 |
| Operating Margin | 27.7% | 36.8% | 37.6% |
| Nonoperating Income | 0.0 | 0.0 | 0.0 |
| Nonoperating Expenses | (162.0) | (228.0) | (302.0) |
| Income Before Taxes | 4,150.0 | 5,317.0 | 5,204.0 |
| Income Taxes | 467.0 | 690.0 | 599.0 |
| Net Income After Taxes | 3,683.0 | 4,627.0 | 4,605.0 |
| Continuing Operations | 3,683.0 | 4,627.0 | 4,605.0 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 3,683.0 | 4,627.0 | 4,605.0 |
| Total Net Income | 3,683.0 | 4,627.0 | 4,605.0 |
| Net Profit Margin | 23.6% | 30.7% | 31.5% |
| Diluted EPS from Total Net Income | 4.04 | 4.79 | 4.51 |
| Dividends per Share | 0.56 | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Amgen Inc. Balance Sheet
| Assets | Dec 11 | Dec 10 | Dec 09 |
| Current Assets | |||
| Cash | -- | 3,287.0 | 2,884.0 |
| Net Receivables | 2,896.0 | 2,335.0 | 2,109.0 |
| Inventories | 2,484.0 | 2,022.0 | 2,220.0 |
| Other Current Assets | 22,213.0 | 15,485.0 | 11,719.0 |
| Total Current Assets | 27,593.0 | 23,129.0 | 18,932.0 |
| Net Fixed Assets | 5,420.0 | 5,522.0 | 5,738.0 |
| Other Noncurrent Assets | 15,858.0 | 14,835.0 | 14,959.0 |
| Total Assets | 48,871.0 | 43,486.0 | 39,629.0 |
| Liabilities | Dec 11 | Dec 10 | Dec 09 |
| Current Liabilities | |||
| Accounts Payable | -- | 716.0 | 574.0 |
| Short-Term Debt | 84.0 | 2,488.0 | 0.0 |
| Other Current Liabilities | 5,670.0 | 3,366.0 | 3,299.0 |
| Total Current Liabilities | 5,754.0 | 6,570.0 | 3,873.0 |
| Long-Term Debt | 21,344.0 | 10,874.0 | 10,601.0 |
| Other Noncurrent Liabilities | 2,744.0 | 2,098.0 | 2,488.0 |
| Total Liabilities | 29,842.0 | 19,542.0 | 16,962.0 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 19,029.0 | 23,944.0 | 22,667.0 |
| Total Equity | 19,029.0 | 23,944.0 | 22,667.0 |
| Shares Outstanding (thou.) | 876,544.3 | 932,000.0 | 995,000.0 |
All amounts in millions of US Dollars except per share amounts.
Amgen Inc. Cash Flow Statement
| Dec 11 | Dec 10 | Dec 09 | |
| Net Operating Cash Flow | -- | 5,787 | 6,336 |
| Net Investing Cash Flow | -- | (4,152.0) | (3,202.0) |
| Net Financing Cash Flow | (1,232.0) | (2,024.0) | |
| Net Change in Cash | 403.0 | 1,110.0 | |
| Depreciation & Amortization | 294.0 | 294.0 | 294.0 |
| Capital Expenditures | (580.0) | (530.0) | |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.


